Ketamine normalizes brain activity during emotionally valenced attentional processing in depression

BACKGROUND: An urgent need exists for faster-acting pharmacological treatments in major depressive disorder (MDD). The glutamatergic modulator ketamine has been shown to have rapid antidepressant effects, but much remains unknown about its mechanism of action. Functional MRI (fMRI) can be used to in...

Descripción completa

Detalles Bibliográficos
Autores principales: Reed, Jessica L., Nugent, Allison C., Furey, Maura L., Szczepanik, Joanna E., Evans, Jennifer W., Zarate, Carlos A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2018
Materias:
Regular Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6070691/
https://www.ncbi.nlm.nih.gov/pubmed/30094160
http://dx.doi.org/10.1016/j.nicl.2018.07.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6070691/
https://www.ncbi.nlm.nih.gov/pubmed/30094160
http://dx.doi.org/10.1016/j.nicl.2018.07.006

Ejemplares similares